Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Wutai Gankang Pharmaceutical Co., Ltd. is a prominent Chinese pharmaceutical company specializing in the development and manufacturing of over-the-counter (OTC) medications. As a core subsidiary of the Jilin Wutai Group, the company is best known for its flagship product, Gankang (Compound Paracetamol and Amantadine Hydrochloride Tablets), which is one of the most widely recognized and top-selling cold and flu treatments in the Chinese market. The company operates large-scale, GMP-certified manufacturing facilities in Changchun, Jilin Province, focusing on high-volume production of oral solid dosage forms. Its business model is built on extensive retail distribution and strong brand recognition, particularly in the respiratory and analgesic categories. Wutai Gankang maintains a dominant position in the domestic consumer health sector through its focus on affordable, effective, and accessible small molecule formulations. The company's portfolio also includes pediatric medicines and gastrointestinal treatments, catering to a broad demographic of Chinese consumers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 吉林省吴太感康药业有限公司.